Thermo Fisher Scientific Stock – Fundamental Analysis
Fundamental Data & Ratios (Balance sheet update: 9/6/2026)
| Balance Sheet | Total Assets | 110,343,000,000.00 | ROE | 48.41 % |
| Balance Sheet | Total Equity | 53,415,000,000.00 | ROA | 6.11 % |
| Cashflow | Capital Expenditures | -1,525,000,000.00 | P/FCF | 40.33 |
| Cashflow | Free Cash Flow | 6,293,000,000.00 | – | – |
| Cashflow | Operating Cash Flow | 7,818,000,000.00 | P/CF | 32.46 |
| Income | Earnings per Share (diluted) | 17.87 | Div. Yield | 0.26 % |
| Income | Net Income | 6,737,000,000.00 | P/E | 37.67 |
| Income | Shares Outstanding | 377,000,000.00 | P/B | 4.75 |
| Income | Total Revenue | 44,556,000,000.00 | P/S | 5.70 |
Ratios calculated on: 10/14/2026
Company Description
Thermo Fisher Scientific Inc. (Thermo Fisher) is engaged in serving science. It operates in three segments: Analytical Technologies, Specialty Diagnostics and Laboratory Products and Services. It serves its customers through three brands: Thermo Scientific, Fisher Scientific and Unity Lab Services. Thermo Scientific is its technology brand. Fisher Scientific is its channels brand. Its Unity Lab Services offers portfolio of enterprise services for instruments and laboratory equipment. Unity Lab Services offers a network of service and support personnel. In April 2012, it opened a new demonstration laboratory and training center in Seoul, South Korea. In May 2012, it acquired Doe & Ingalls Management, LLC. In September 2012, it acquired One Lambda, Inc. In September 2012, Thermo Fisher opened its Molecular Biology Center of Excellence in Vilnius, Lithuania. In October 2012, OpenGate Capital, LLC acquired the Laboratory (Lab) Workstations business from Thermo Fisher.
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.thermofisher.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more